The Lebanese Order of Dietitians, in collaboration with Novo Nordisk, hosted a scientific meeting on June 24, 2026, at the Phoenicia InterContinental Hotel, Beirut, dedicated to the latest advances in obesity and weight management
The event featured insightful presentations on Semaglutide 2.4 mg in weight management and nutritional considerations for patients receiving GLP-1 receptor agonist therapy, highlighting the importance of integrating medical and nutrition care to optimize patient outcomes
We extend our sincere appreciation to our distinguished speakers, Dr. Carole Saade Riachy and Dr. Sally Sawaya, for sharing their expertise, and to all attendees for their engagement and commitment to advancing evidence-based practice
Together, we continue to strengthen the role of dietitians as essential partners in the management of obesity and the promotion of long-term health
